IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.923
AS - Asia 3.859
EU - Europa 3.069
SA - Sud America 920
AF - Africa 99
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.880
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.774
SG - Singapore 1.493
CN - Cina 1.087
BR - Brasile 777
IT - Italia 533
HK - Hong Kong 504
DE - Germania 452
UA - Ucraina 443
PL - Polonia 401
FI - Finlandia 314
RU - Federazione Russa 222
VN - Vietnam 189
GB - Regno Unito 178
TR - Turchia 160
IE - Irlanda 132
FR - Francia 100
IN - India 91
CA - Canada 90
SE - Svezia 61
ID - Indonesia 59
CZ - Repubblica Ceca 56
AR - Argentina 51
BD - Bangladesh 50
JP - Giappone 44
ZA - Sudafrica 41
NL - Olanda 39
MX - Messico 35
IQ - Iraq 31
AT - Austria 30
BE - Belgio 26
EC - Ecuador 25
PK - Pakistan 25
ES - Italia 20
UZ - Uzbekistan 18
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
CO - Colombia 12
MA - Marocco 12
PY - Paraguay 12
EG - Egitto 11
PE - Perù 11
VE - Venezuela 11
CL - Cile 10
LT - Lituania 10
AZ - Azerbaigian 9
CH - Svizzera 9
GR - Grecia 9
PT - Portogallo 9
DZ - Algeria 8
JO - Giordania 8
IL - Israele 7
AU - Australia 6
JM - Giamaica 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
IR - Iran 5
KE - Kenya 5
KZ - Kazakistan 5
LB - Libano 5
LY - Libia 5
PA - Panama 5
CR - Costa Rica 4
CY - Cipro 4
ET - Etiopia 4
KG - Kirghizistan 4
LV - Lettonia 4
MU - Mauritius 4
PH - Filippine 4
BO - Bolivia 3
EE - Estonia 3
EU - Europa 3
KR - Corea 3
LK - Sri Lanka 3
NP - Nepal 3
RO - Romania 3
BG - Bulgaria 2
HN - Honduras 2
NO - Norvegia 2
OM - Oman 2
TG - Togo 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 15.871
Salva come PNG Salva come JPEG
Città #
Fairfield 746
Ashburn 687
Singapore 654
Woodbridge 532
Hong Kong 494
Warsaw 396
Houston 395
Dallas 321
Seattle 312
Jacksonville 309
Cambridge 305
Chandler 301
Beijing 291
Wilmington 266
Los Angeles 259
Chicago 255
New York 244
Princeton 178
Helsinki 174
Ann Arbor 166
Munich 141
Istanbul 131
Salt Lake City 107
Dublin 100
Buffalo 94
Moscow 90
Nanjing 87
Brescia 80
Turku 78
São Paulo 73
Boardman 72
Ho Chi Minh City 69
Shanghai 68
Redondo Beach 66
Des Moines 58
The Dalles 58
Secaucus 55
San Francisco 54
Tampa 52
Dearborn 50
Elk Grove Village 50
Jakarta 50
Milan 43
Brno 42
Lancaster 42
Changsha 37
London 37
Nanchang 37
San Diego 35
Brooklyn 34
Santa Clara 33
Dong Ket 32
Nuremberg 30
Washington 30
Dalmine 29
Romola 29
Rio de Janeiro 28
Sterling 28
Shenyang 27
Brussels 26
Hanoi 26
West Jordan 26
Montreal 25
Lappeenranta 24
Poplar 24
Stockholm 24
Belo Horizonte 23
Tokyo 23
Boston 22
Menlo Park 22
Phoenix 22
Tianjin 21
Toronto 21
Jinan 20
Johannesburg 20
Atlanta 19
Chennai 19
Denver 19
Naples 19
Vienna 18
Guangzhou 17
Tashkent 17
Dulles 16
Hebei 16
Zhengzhou 16
Ankara 15
Curitiba 15
Charlotte 14
Düsseldorf 14
Hangzhou 14
Orem 13
Verona 13
Kunming 12
New Delhi 12
Olomouc 12
Turin 12
Vignate 12
Jiaxing 11
Mexico City 11
Amsterdam 10
Totale 10.276
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 757
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 355
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 227
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 220
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 213
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 205
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 200
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 198
Immunotherapy failure in adrenocortical cancer: where next? 193
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 188
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 187
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 187
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 186
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 183
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 182
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 180
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 171
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 167
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 166
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 159
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 158
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 157
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 156
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 154
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 154
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 153
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 150
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 149
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 148
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 144
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 143
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 139
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 138
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 137
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 137
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 135
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 135
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 135
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 134
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 133
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 132
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 131
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 131
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 127
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 126
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 123
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 121
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 120
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 117
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 117
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 116
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 116
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 114
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 112
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 109
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 108
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 107
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 105
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 103
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 103
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 102
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 98
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 97
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 96
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 94
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 94
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 91
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 90
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 89
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 89
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 87
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 87
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 86
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 85
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 85
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 84
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 84
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 83
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 83
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 81
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 81
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 81
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 79
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 78
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 78
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 78
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 78
Needs in breast cancer patients (pts) during chemotherapy: Customer satisfaction evaluation 77
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 77
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 77
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 76
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 74
TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma 74
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 73
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 73
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 72
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 72
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 69
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 69
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 69
Totale 13.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.103 0 0 0 0 103 173 52 171 150 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20254.477 50 47 62 557 406 297 276 151 457 288 1.014 872
2025/20263.678 667 1.045 733 955 278 0 0 0 0 0 0 0
Totale 16.192